![Sultan A. Baig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 300 214 $ in data 31/05/2026
Sultan A. Baig currently works at The Institute of Chartered Accountants of India, as Member.
Mr. Baig also formerly worked at Biological E.
Ltd., as Vice President-Finance and Nava Ltd., as Chief Financial Officer from 2020 to 2025.
Mr. Baig received his undergraduate degree from the University of Pune.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NAVA LIMITED 0,02% | 21/11/2024 | 48.018 ( 0,02% ) | 300 214 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
The Institute of Chartered Accountants of India
 The Institute of Chartered Accountants of India Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| NAVA LIMITED | Direttore Finanziario/CFO | 07/02/2025 |
Biological E. Ltd.
 Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures liver extracts and anti-coagulants for treating diseases | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Nava Ltd.
 Nava Ltd. Electric UtilitiesUtilities Manufactures ferro alloys, sugar, mining and power generation | Utilities |
University of Pune
 University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Institute of Chartered Accountants of India
The Institute of Chartered Accountants of India Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biological E. Ltd.
Biological E. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures liver extracts and anti-coagulants for treating diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
